A phase I dose escalation study to test the safety of intratumoral adoptive immune therapy with alloctl in recurrent glioma patients

The requested reference [70c116cf7f42bffe40406b5650c6bb53063ff609] no longer exists in our database. It has been replaced by the current reference: [ad0e426fe6e7dc5884237938fb0e43ae0b638651]

Authors
Category Primary study
JournalNeuro-Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 5ded19b84ed02acb93b50137e93800955857ce5c
First added on: Feb 07, 2025